title: Fifteen years of population based experience in Finland with a plasma-derived monoclonal purified factor VIII concentrate.
authors.forename: A
authors.initials: A
authors.lastname: Mäkipernaa
authors.forename: L
authors.initials: L
authors.lastname: von Bonsdorff
mesh_terms: D000328:Adult; D002648:Child; D002675:Child, Preschool; D003029:Coagulants / Q000592:standards / Q000627:therapeutic use*; D005169:Factor VIII / Q000592:standards / Q000627:therapeutic use*; D005387:Finland / Q000453:epidemiology; D006467:Hemophilia A / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D011358:Product Surveillance, Postmarketing; D014777:Virus Diseases / Q000517:prevention & control / Q000635:transmission
chemical_list: D003029:Coagulants; D005169:Factor VIII